TWST Twist Bioscience Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: TWST

Price (delayed)

$74.34

Market cap

$4.63B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.32

Enterprise value

$4.62B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 37

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of ...

Highlights
TWST's gross profit is up by 31% year-on-year and by 5% since the previous quarter
TWST's revenue is up by 18% YoY and by 4.6% from the previous quarter
TWST's EPS has surged by 59% year-on-year but it is down by 3.9% since the previous quarter
The net income has soared by 57% YoY but it fell by 6% QoQ
TWST's quick ratio has dropped by 52% year-on-year and by 36% since the previous quarter
Twist Bioscience's debt has increased by 16% YoY
Sector: Healthcare
Industry: Diagnostics & Research
Website: https://www.twistbioscience.com/
Peers: NVAX NVCR NBIX

Key stats

What are the main financial stats of TWST

TWST stock price

How has the Twist Bioscience stock price performed over time
Intraday
2.78%
1 week
7.69%
1 month
32.3%
1 year
144.22%
YTD
134.36%
QTD
56.44%

Financial performance

How have Twist Bioscience's revenue and profit performed over time
Revenue
$409.48M
Gross profit
$213.23M
Operating income
-$138.82M
Net income
-$81.28M
Gross margin
52.1%
Net margin
-19.8%
Twist Bioscience's net margin has soared by 64% YoY
The net income has soared by 57% YoY but it fell by 6% QoQ
Twist Bioscience's operating margin has increased by 41% YoY
TWST's gross profit is up by 31% year-on-year and by 5% since the previous quarter

Price vs fundamentals

How does TWST's price correlate with its fundamentals

Growth

What is Twist Bioscience's growth rate over time

Valuation

What is Twist Bioscience stock price valuation
P/E
N/A
P/B
10.02
P/S
11.2
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
11.28
TWST's EPS has surged by 59% year-on-year but it is down by 3.9% since the previous quarter
TWST's P/B is 116% above its 5-year quarterly average of 4.5 and 107% above its last 4 quarters average of 4.7
Twist Bioscience's equity has increased by 3.4% YoY
TWST's P/S is 91% above its last 4 quarters average of 5.7 but 11% below its 5-year quarterly average of 12.2
TWST's revenue is up by 18% YoY and by 4.6% from the previous quarter

Efficiency

How efficient is Twist Bioscience business performance
Twist Bioscience's ROIC has soared by 67% YoY and by 2.9% from the previous quarter
TWST's return on sales has surged by 64% year-on-year but it is down by 2.1% since the previous quarter
The ROA has soared by 60% YoY but it has decreased by 2.5% from the previous quarter
The return on equity has surged by 57% year-on-year but it has declined by 5% since the previous quarter

Dividends

What is TWST's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TWST.

Financial health

How did Twist Bioscience financials performed over time
TWST's quick ratio has dropped by 52% year-on-year and by 36% since the previous quarter
Twist Bioscience's total liabilities has increased by 42% YoY and by 22% QoQ
Twist Bioscience's debt is 76% less than its equity
Twist Bioscience's debt has increased by 16% YoY
Twist Bioscience's debt to equity has increased by 9% YoY but it has decreased by 4% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.